Diffuse plasmacytosis in a child with brainstem glioma following multiagent chemotherapy and intensive growth factor support

Csilla Csáki, Thomas Ferencz, György Sipos, L. Kópper, D. Schuler, Joseph D. Borsi

Research output: Article

1 Citation (Scopus)

Abstract

The use of granulocyte colony-stimulating factor (G-CSF) or granulocyte- macrophage-colony-stimulating factor (GM-CSF) in order to abrogate chemotherapy-induced neutropenia has become a routine part of many cancer treatment regimens. However, there are still very few data available about possible complications related to repeated or prolonged use of these agents in patients with malignant solid tumors. The authors report a child with brainstem glioma who received repeated cycles of multiagent chemotherapy with G- or GM-CSF support. During this period of 10 months, no clinical side effects were observed that could have been attributed to growth factor administration. However, postmortem histological examination revealed the presence of diffuse plasmacytosis, a rare hematological disorder in childhood. Undifferentiated plasma cells of nonmonoclonal origin could be demonstrated infiltrating bone marrow, lungs, and lymph nodes of the patient. Based on previously published in vitro and in vivo evidence on the interleukin-6 (IL-6)-mediated stimulatory effect of G- and GM-CSF on myeloma cell proliferation, the authors suggest a possible link between extensive growth factor support and the development of plasmacytosis in this patient.

Original languageEnglish
Pages (from-to)367-371
Number of pages5
JournalMedical and Pediatric Oncology
Volume26
Issue number5
DOIs
Publication statusPublished - máj. 1996

Fingerprint

Granulocyte-Macrophage Colony-Stimulating Factor
Glioma
Brain Stem
Intercellular Signaling Peptides and Proteins
Drug Therapy
Proxy
Granulocyte Colony-Stimulating Factor
Plasma Cells
Neutropenia
Autopsy
Interleukin-6
Neoplasms
Lymph Nodes
Bone Marrow
Cell Proliferation
Lung
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research

Cite this

Diffuse plasmacytosis in a child with brainstem glioma following multiagent chemotherapy and intensive growth factor support. / Csáki, Csilla; Ferencz, Thomas; Sipos, György; Kópper, L.; Schuler, D.; Borsi, Joseph D.

In: Medical and Pediatric Oncology, Vol. 26, No. 5, 05.1996, p. 367-371.

Research output: Article

@article{162977fe74f240d695ffe3d30729bc02,
title = "Diffuse plasmacytosis in a child with brainstem glioma following multiagent chemotherapy and intensive growth factor support",
abstract = "The use of granulocyte colony-stimulating factor (G-CSF) or granulocyte- macrophage-colony-stimulating factor (GM-CSF) in order to abrogate chemotherapy-induced neutropenia has become a routine part of many cancer treatment regimens. However, there are still very few data available about possible complications related to repeated or prolonged use of these agents in patients with malignant solid tumors. The authors report a child with brainstem glioma who received repeated cycles of multiagent chemotherapy with G- or GM-CSF support. During this period of 10 months, no clinical side effects were observed that could have been attributed to growth factor administration. However, postmortem histological examination revealed the presence of diffuse plasmacytosis, a rare hematological disorder in childhood. Undifferentiated plasma cells of nonmonoclonal origin could be demonstrated infiltrating bone marrow, lungs, and lymph nodes of the patient. Based on previously published in vitro and in vivo evidence on the interleukin-6 (IL-6)-mediated stimulatory effect of G- and GM-CSF on myeloma cell proliferation, the authors suggest a possible link between extensive growth factor support and the development of plasmacytosis in this patient.",
keywords = "chemotherapy, G-CSF, glioma, GM-CSF, growth factor, plasmacytosis",
author = "Csilla Cs{\'a}ki and Thomas Ferencz and Gy{\"o}rgy Sipos and L. K{\'o}pper and D. Schuler and Borsi, {Joseph D.}",
year = "1996",
month = "5",
doi = "10.1002/(SICI)1096-911X(199605)26:5<367::AID-MPO10>3.0.CO;2-A",
language = "English",
volume = "26",
pages = "367--371",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Diffuse plasmacytosis in a child with brainstem glioma following multiagent chemotherapy and intensive growth factor support

AU - Csáki, Csilla

AU - Ferencz, Thomas

AU - Sipos, György

AU - Kópper, L.

AU - Schuler, D.

AU - Borsi, Joseph D.

PY - 1996/5

Y1 - 1996/5

N2 - The use of granulocyte colony-stimulating factor (G-CSF) or granulocyte- macrophage-colony-stimulating factor (GM-CSF) in order to abrogate chemotherapy-induced neutropenia has become a routine part of many cancer treatment regimens. However, there are still very few data available about possible complications related to repeated or prolonged use of these agents in patients with malignant solid tumors. The authors report a child with brainstem glioma who received repeated cycles of multiagent chemotherapy with G- or GM-CSF support. During this period of 10 months, no clinical side effects were observed that could have been attributed to growth factor administration. However, postmortem histological examination revealed the presence of diffuse plasmacytosis, a rare hematological disorder in childhood. Undifferentiated plasma cells of nonmonoclonal origin could be demonstrated infiltrating bone marrow, lungs, and lymph nodes of the patient. Based on previously published in vitro and in vivo evidence on the interleukin-6 (IL-6)-mediated stimulatory effect of G- and GM-CSF on myeloma cell proliferation, the authors suggest a possible link between extensive growth factor support and the development of plasmacytosis in this patient.

AB - The use of granulocyte colony-stimulating factor (G-CSF) or granulocyte- macrophage-colony-stimulating factor (GM-CSF) in order to abrogate chemotherapy-induced neutropenia has become a routine part of many cancer treatment regimens. However, there are still very few data available about possible complications related to repeated or prolonged use of these agents in patients with malignant solid tumors. The authors report a child with brainstem glioma who received repeated cycles of multiagent chemotherapy with G- or GM-CSF support. During this period of 10 months, no clinical side effects were observed that could have been attributed to growth factor administration. However, postmortem histological examination revealed the presence of diffuse plasmacytosis, a rare hematological disorder in childhood. Undifferentiated plasma cells of nonmonoclonal origin could be demonstrated infiltrating bone marrow, lungs, and lymph nodes of the patient. Based on previously published in vitro and in vivo evidence on the interleukin-6 (IL-6)-mediated stimulatory effect of G- and GM-CSF on myeloma cell proliferation, the authors suggest a possible link between extensive growth factor support and the development of plasmacytosis in this patient.

KW - chemotherapy

KW - G-CSF

KW - glioma

KW - GM-CSF

KW - growth factor

KW - plasmacytosis

UR - http://www.scopus.com/inward/record.url?scp=0029869057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029869057&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-911X(199605)26:5<367::AID-MPO10>3.0.CO;2-A

DO - 10.1002/(SICI)1096-911X(199605)26:5<367::AID-MPO10>3.0.CO;2-A

M3 - Article

C2 - 8614371

AN - SCOPUS:0029869057

VL - 26

SP - 367

EP - 371

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 5

ER -